Joana Pereira

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Amyloid 86%
3. Brain 59%
4. Dementia 50%
5. Pathology 48%
6. Biomarkers 48%
7. White Matter 45%
8. Parkinson Disease 44%
9. Connectome 42%
10. Atrophy 41%
11. Cognitive Dysfunction 32%
12. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 32%
13. Gray Matter 31%
14. Neurodegenerative Diseases 27%
15. Positron-Emission Tomography 26%
16. Cluster Analysis 23%
17. Cognition 21%
18. Lewy Body Disease 21%
19. Cerebrospinal Fluid 21%
20. Cerebrovascular Disorders 21%
21. Neuroimaging 19%
22. Healthy Aging 19%
23. Sex Characteristics 19%
24. Magnetic Resonance Imaging 19%
25. Deep Learning 18%
26. Apolipoproteins E 16%
27. Basal Nucleus of Meynert 15%
28. Memory 15%
29. Carboxy-Lyases 13%
30. Progressive Supranuclear Palsy 13%
31. Multiple System Atrophy 13%
32. Confidence Intervals 13%
33. Lewy Bodies 13%
34. Basal Forebrain 12%
35. Parkinsonian Disorders 12%
36. Dendritic Spines 12%
37. Behavioral Symptoms 12%
38. Cholinergic Agents 12%
39. Molecular Imaging 12%
40. Parietal Lobe 11%
41. Intermediate Filaments 11%
42. Prothrombin Time 11%
43. Primary Spontaneous Pneumothorax 11%
44. Diffusion Tensor Imaging 11%
45. Individuality 11%
46. Efficiency 11%
47. Neurogranin 10%
48. External Capsule 10%
49. Skull 10%
50. Cerebrovascular Circulation 9%